Clinical Trials Directory

Trials / Sponsors / Tasly Biopharmaceuticals Co., Ltd.

Tasly Biopharmaceuticals Co., Ltd.

Industry · 9 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Recruitinga Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Pa
NAFLD (Non-alcoholic Fatty Liver Disease), NASH (Nonalcoholic Steatohepatitis)
Phase 12025-07-24
Not Yet RecruitingA Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Tre
Advanced Colorectal Cancer
Phase 22025-02-24
Not Yet RecruitingA Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in t
Recurrent Platinum-resistant Epithelial Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Cervical Cancers
Phase 22024-12-01
CompletedrhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)
Acute Ischemic Stroke
Phase 32023-01-29
UnknownA Study of B1962, a PD-L1/VEGF Bispecific Antibody Fusion Protein, for Advanced Solid Tumors
Neoplasms Malignant
Phase 12022-12-01
UnknownA Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy
Nonalcoholic Steatohepatitis
Phase 12022-08-30
CompletedThrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
Acute Ischaemic Stroke
Phase 32018-08-10
CompletedStudy of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)
Acute Ischaemic Stroke
Phase 32018-05-18
CompletedA Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism
Acute Pulmonary Embolism
Phase 22017-06-06